First Time Loading...
A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 25 914.9004 INR 0.81%
Updated: Apr 26, 2024

Intrinsic Value

Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. [ Read More ]

The intrinsic value of one ABBOTINDIA stock under the Base Case scenario is 13 856.7389 INR. Compared to the current market price of 25 914.9004 INR, Abbott India Ltd is Overvalued by 47%.

Key Points:
ABBOTINDIA Intrinsic Value
Base Case
13 856.7389 INR
Overvaluation 47%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
Abbott India Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ABBOTINDIA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Abbott India Ltd

Provide an overview of the primary business activities
of Abbott India Ltd.

What unique competitive advantages
does Abbott India Ltd hold over its rivals?

What risks and challenges
does Abbott India Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Abbott India Ltd.

Provide P/S
for Abbott India Ltd.

Provide P/E
for Abbott India Ltd.

Provide P/OCF
for Abbott India Ltd.

Provide P/FCFE
for Abbott India Ltd.

Provide P/B
for Abbott India Ltd.

Provide EV/S
for Abbott India Ltd.

Provide EV/GP
for Abbott India Ltd.

Provide EV/EBITDA
for Abbott India Ltd.

Provide EV/EBIT
for Abbott India Ltd.

Provide EV/OCF
for Abbott India Ltd.

Provide EV/FCFF
for Abbott India Ltd.

Provide EV/IC
for Abbott India Ltd.

Show me price targets
for Abbott India Ltd made by professional analysts.

What are the Revenue projections
for Abbott India Ltd?

How accurate were the past Revenue estimates
for Abbott India Ltd?

What are the Net Income projections
for Abbott India Ltd?

How accurate were the past Net Income estimates
for Abbott India Ltd?

What are the EPS projections
for Abbott India Ltd?

How accurate were the past EPS estimates
for Abbott India Ltd?

What are the EBIT projections
for Abbott India Ltd?

How accurate were the past EBIT estimates
for Abbott India Ltd?

Compare the revenue forecasts
for Abbott India Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Abbott India Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Abbott India Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Abbott India Ltd compared to its peers.

Compare the P/E ratios
of Abbott India Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Abbott India Ltd with its peers.

Analyze the financial leverage
of Abbott India Ltd compared to its main competitors.

Show all profitability ratios
for Abbott India Ltd.

Provide ROE
for Abbott India Ltd.

Provide ROA
for Abbott India Ltd.

Provide ROIC
for Abbott India Ltd.

Provide ROCE
for Abbott India Ltd.

Provide Gross Margin
for Abbott India Ltd.

Provide Operating Margin
for Abbott India Ltd.

Provide Net Margin
for Abbott India Ltd.

Provide FCF Margin
for Abbott India Ltd.

Show all solvency ratios
for Abbott India Ltd.

Provide D/E Ratio
for Abbott India Ltd.

Provide D/A Ratio
for Abbott India Ltd.

Provide Interest Coverage Ratio
for Abbott India Ltd.

Provide Altman Z-Score Ratio
for Abbott India Ltd.

Provide Quick Ratio
for Abbott India Ltd.

Provide Current Ratio
for Abbott India Ltd.

Provide Cash Ratio
for Abbott India Ltd.

What is the historical Revenue growth
over the last 5 years for Abbott India Ltd?

What is the historical Net Income growth
over the last 5 years for Abbott India Ltd?

What is the current Free Cash Flow
of Abbott India Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Abbott India Ltd.

Financials

Balance Sheet Decomposition
Abbott India Ltd

Current Assets 29.5B
Cash & Short-Term Investments 643.1m
Receivables 3.8B
Other Current Assets 25.1B
Non-Current Assets 15.7B
Long-Term Investments 12.7B
PP&E 2.3B
Intangibles 69m
Other Non-Current Assets 609.8m
Current Liabilities 12.5B
Accounts Payable 8.9B
Other Current Liabilities 3.5B
Non-Current Liabilities 1.6B
Long-Term Debt 451.4m
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
Abbott India Ltd

Revenue
44.1B INR
Cost of Revenue
-24.1B INR
Gross Profit
20B INR
Operating Expenses
-9.2B INR
Operating Income
10.7B INR
Other Expenses
-1.6B INR
Net Income
9.1B INR

Free Cash Flow Analysis
Abbott India Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ABBOTINDIA Profitability Score
Profitability Due Diligence

Abbott India Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Free Cash Flow
69/100
Profitability
Score

Abbott India Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

ABBOTINDIA Solvency Score
Solvency Due Diligence

Abbott India Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
77/100
Solvency
Score

Abbott India Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABBOTINDIA Price Targets Summary
Abbott India Ltd

Wall Street analysts forecast ABBOTINDIA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBOTINDIA is 29 291.17 INR with a low forecast of 25 957 INR and a high forecast of 34 650 INR.

Lowest
Price Target
25 957 INR
0% Upside
Average
Price Target
29 291.17 INR
13% Upside
Highest
Price Target
34 650 INR
34% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ABBOTINDIA Price
Abbott India Ltd

1M 1M
-3%
6M 6M
+17%
1Y 1Y
+16%
3Y 3Y
+75%
5Y 5Y
+256%
10Y 10Y
+1 449%
Annual Price Range
25 914.9004
52w Low
20 898.45
52w High
29 538.6
Price Metrics
Average Annual Return 33.14%
Standard Deviation of Annual Returns 29.17%
Max Drawdown -14%
Shares Statistics
Market Capitalization 546.3B INR
Shares Outstanding 21 250 513
Percentage of Shares Shorted
N/A

ABBOTINDIA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Abbott India Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

546.3B INR

Dividend Yield

0.69%

Description

Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 3,597 full-time employees. The firm has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. The company provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. The company offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.

Contact

MAHARASHTRA
Mumbai
16th Floor, Godrej BKC,, Plot-C,G Block,, Bandra-Kurla Complex,Bandra (East)
+912238162000
http://www.abbott.co.in/

IPO

1994-11-03

Employees

3 597

Officers

Chief Financial Officer
Mr. Sridhar Kadangode
Company Secretary & Compliance Officer
Ms. Sangeeta Mukesh Shetty
Director of Business Human Resources
Mr. Rajan Kalantre

See Also

Discover More
What is the Intrinsic Value of one ABBOTINDIA stock?

The intrinsic value of one ABBOTINDIA stock under the Base Case scenario is 13 856.7389 INR.

Is ABBOTINDIA stock undervalued or overvalued?

Compared to the current market price of 25 914.9004 INR, Abbott India Ltd is Overvalued by 47%.